Purity Raw Material Cetilistat Powder Cetilistat

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: QS-Cetilistat
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• CAS No: 282526-98-1
• MW: 401.591
• Mf: C25h39no3
• Einecs No: 1308068-626-2
• Melting Point: 72.0 to 76.0 °c
• Boiling Point: 509.671 °c at 760 Mmhg
• Density: 1.02
• Refractive Index: 1.521
• Store: Cool and Dry
• Grade: Pharmaceutical Grade
• Assay: 99%
• Test Method: HPLC
• Specific: COA
• Product Name: Cetilistat
• Name: Cetilistat Powder
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS-Cetilistat
• Origin: Shaanxi Xi′an
• Production Capacity: 2000kg/Month

Product Description

Purity Raw Material Cetilistat Powder Cetilistat

Product Description

Product Details

Product Name	Cetilistat
Appearance	White Powder
CAS NO	282526-98-1
MF	C25H39NO3
MW	401.591

 a commonly used drug for treating obesity. As the active ingredient of weight loss drugs, its unique mechanism of action has brought important impetus to the innovation and development of the weight loss drug market. Xinlisitaka regulates the appetite center by affecting the reuptake of neurotransmitters, thereby reducing calorie intake, increasing satiety, and promoting weight loss. Its unique mechanism of action and effects have injected new vitality and possibilities into the field of weight loss drugs.

Application&Function

In the treatment of obesity, the application of neonicotinoid has brought new ideas for the innovation of weight loss drugs. Traditional weight loss drugs often achieve weight loss by suppressing appetite or accelerating metabolism, while neonicotinoids regulate neurotransmitters to change the perception and control of food in the brain, making it easier for patients to control their diet and reduce their food intake, thereby achieving weight loss. This unique working mechanism provides new ideas and directions for the development of weight loss drugs.
The effectiveness and safety of Xinlisi also provide strong support for the development of the weight loss drug market. Clinical studies have shown that neonicotinoid can significantly reduce body weight, waist circumference, and body fat content, and has a significant weight loss effect on obese patients. Compared with traditional weight loss drugs, Sillistat has shown excellent weight loss effects and tolerability, providing a more effective and safe treatment option for obese patients.

Specification